In light of RxPonder results for postmenopausal women with early stage node positive HR+HER2- breast cancer, when is there a role for full axillary LN dissection to confirm degree of nodal involvement and when would sentinel LN evaluation be sufficient?  

How would this affect adjuvant radiation plan in breast conservation therapy patients and mastectomy patients?



Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Moffitt Cancer Center and Rsrch Inst
In RxPonder study, only 61% of patients had node d...
Sign in or Register to read more